Last updated: July 10, 2026

Application No. 19/418,783

Untitled Application

Unknown

Filed

1600

Priority

Mar 24, 2020 — provisional 62/993,930 +3 more

Examiner

ALLEN, MARIANNE P

Art Unit

1647

Tech Center

Genentech, Inc.

Assignee

Genentech Inc.

OA Round

1 (Non-Final)

This examiner grants 60% of cases after interview

— +18.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 995 resolved cases, 2023–2026

Examiner Intelligence

ALLEN, MARIANNE P View full profile →

Grants 60% of resolved cases

Career Allowance Rate

598 granted / 995 resolved

At TC average

Strong +18% interview lift

Without

With

+18.3%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

44 currently pending

Career history

1044

Total Applications

across all art units

Statute-Specific Performance

§101

0.4%

-39.6% vs TC avg

§103

32.1%

-7.9% vs TC avg

§102

15.7%

-24.3% vs TC avg

§112

42.9%

+2.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 995 resolved cases

Prosecution Timeline

1600

Application Filed

Apr 01, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/408,893

Patent 12662525

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

4y 10m to grant Granted Jun 23, 2026

17/727,120

Patent 12653863

FGF21 COMPOSITIONS FOR TREATMENT OR PREVENTION OF NEOVASCULARIZATION OF THE EYE AND METHODS THEREFOR

4y 1m to grant Granted Jun 16, 2026

14/128,681

Patent 12630609

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

12y 2m to grant Granted May 19, 2026

17/453,981

Patent 12617848

METHODS OF TREATING OCULAR PATHOLOGIES USING BIFUNCTIONAL MOLECULES THAT TARGET GROWTH FACTORS

4y 5m to grant Granted May 05, 2026

18/087,045

Patent 12612440

MODIFIED BOVINE G-CSF POLYPEPTIDES AND THEIR USES

3y 4m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

60%

Grant Probability

78%

With Interview (+18.3%)

2y 10m

Median Time to Grant

Low

PTA Risk

Based on 995 resolved cases by this examiner. Grant probability derived from career allowance rate.